Giladi N - Search Results

1

The role of functional neurosurgery in Parkinson's disease.

Giladi N, Melamed E. Giladi N, et al. Isr Med Assoc J. 2000 Jun;2(6):455-61. Isr Med Assoc J. 2000. PMID: 10897238 Free article. Review. No abstract available.

2

Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.

Giladi N, Melamed E. Giladi N, et al. Mov Disord. 1999 Jan;14(1):158-9. doi: 10.1002/1531-8257(199901)14:1<158::aid-mds1028>3.0.co;2-q. Mov Disord. 1999. PMID: 9918362 No abstract available.

3

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.

Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, Simon ES, Korczyn AD. Giladi N, et al. J Neural Transm (Vienna). 2000;107(1):59-71. doi: 10.1007/s007020050005. J Neural Transm (Vienna). 2000. PMID: 10809404

4

Hereditary juvenile-onset craniocervical predominant generalized dystonia with parkinsonism.

Mazarib A, Simon ES, Korczyn AD, Falik-Zaccai Z, Gazit E, Giladi N. Mazarib A, et al. Among authors: giladi n. Isr Med Assoc J. 2000 Jul;2(7):529-31. Isr Med Assoc J. 2000. PMID: 10979329

5

Freezing of gait in patients with advanced Parkinson's disease.

Giladi N, Treves TA, Simon ES, Shabtai H, Orlov Y, Kandinov B, Paleacu D, Korczyn AD. Giladi N, et al. J Neural Transm (Vienna). 2001;108(1):53-61. doi: 10.1007/s007020170096. J Neural Transm (Vienna). 2001. PMID: 11261746

6

Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa.

Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G; Rasagiline Study Group. Rabey JM, et al. Among authors: giladi n. Clin Neuropharmacol. 2000 Nov-Dec;23(6):324-30. doi: 10.1097/00002826-200011000-00005. Clin Neuropharmacol. 2000. PMID: 11575866 Clinical Trial.

7

Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.

Djaldetti R, Inzelberg R, Giladi N, Korczyn AD, Peretz-Aharon Y, Rabey MJ, Herishano Y, Honigman S, Badarny S, Melamed E. Djaldetti R, et al. Among authors: giladi n. Mov Disord. 2002 Mar;17(2):297-302. doi: 10.1002/mds.10075. Mov Disord. 2002. PMID: 11921115 Clinical Trial.

8

Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.

Hausdorff JM, Schaafsma JD, Balash Y, Bartels AL, Gurevich T, Giladi N. Hausdorff JM, et al. Among authors: giladi n. Exp Brain Res. 2003 Mar;149(2):187-94. doi: 10.1007/s00221-002-1354-8. Epub 2003 Jan 22. Exp Brain Res. 2003. PMID: 12610686

9

Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study.

Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E. Djaldetti R, et al. Among authors: giladi n. Clin Neuropharmacol. 2003 Nov-Dec;26(6):322-6. doi: 10.1097/00002826-200311000-00012. Clin Neuropharmacol. 2003. PMID: 14646613 Clinical Trial.

10

Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease.

Merims D, Shabtai H, Korczyn AD, Peretz C, Weizman N, Giladi N. Merims D, et al. Among authors: giladi n. J Neural Transm (Vienna). 2004 Oct;111(10-11):1447-53. doi: 10.1007/s00702-004-0209-9. J Neural Transm (Vienna). 2004. PMID: 15480845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters